3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Primary Myelofibrosis
39
Myeloproliferative Disorders
30
Leukemia, Myeloid, Acute
23
Polycythemia Vera
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Leukemia
17
Myelodysplastic Syndromes
15
Thrombocythemia, Essential
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Neoplasms
9
Multiple Myeloma
9
Graft vs Host Disease
9
Breast Neoplasms
9
Pancreatic Neoplasms
8
Leukemia, Myelomonocytic, Chronic
8
Recurrence
7
Myelodysplastic-Myeloproliferative Diseases
7
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Hematologic Neoplasms
6
Prostatic Neoplasms
5
Lymphoma, T-Cell
5
Lymphoma
5
Leukemia, Myeloid, Chronic-Phase
5
Hodgkin Disease
5
Hematologic Diseases
5
Colorectal Neoplasms
5
Thrombocytosis
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Carcinoma, Non-Small-Cell Lung
4
Interventions
Tamoxifen
21
Radiotherapy
9
Chemotherapy, Adjuvant
9
Early Intervention, Educational
8
Specimen Handling
7
Anastrozole
7
Neoadjuvant Therapy
6
Methods
6
Letrozole
6
Practice Guidelines as Topic
5
Counseling
5
Biopsy
5
Standard of Care
4
Magnetic Resonance Spectroscopy
4
Educational Status
4
Behavior Therapy
4
exemestane
3
Radiation Dose Hypofractionation
3
Radiation
3
Psychiatric Rehabilitation
3
Mastectomy, Segmental
3
Brachytherapy
3
Therapeutics
2
Telemedicine
2
Taxes
2
Surveys and Questionnaires
2
Soybean Proteins
2
Simvastatin
2
Radiotherapy, Conformal
2
Proton Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Carcinoma In Situ
×
ruxolitinib
×
Clear all
NCT02928978
2026-04-13
TBCRC042
Baylor Breast Care Center
Phase 2
Completed
84 enrolled